CSIMarket
 


Harmony Biosciences Holdings inc   (HRMY)
Other Ticker:  
 


Harmony Biosciences Holdings Inc 's Effective Tax Rate by quarter

Trends, Rankings, Statistics



HRMY Effective Tax Rate (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Pre-Tax Income Change -10.01 % 550.58 % 50.85 % 61.56 % 80.2 %
Seq. Pre-Tax Income Change -23.43 % 17.55 % 16.72 % -14.34 % 453.57 %
Pre-Tax Income In Millions $39.69 $51.83 $44.10 $37.78 $44.10
Effective Tax Rate 32.96 % 25.8 % 22.21 % 21.96 % -9.99 %
Effective Tax Rate Total Ranking # 1249 # 1506 # 1012 # 1007 #
Income taxes expenses / -benefit In Millions $13.08 $13.37 $9.80 $8.30 $-4.41
Y / Y Income taxes expenses / -benefit Change - - 71.84 % 336.58 % -
Seq. Income taxes expenses / -benefit Change -2.16 % 36.51 % 18.08 % - -


Commenting fourth Quarter 2023 Effective Tax Rate
Company's effective tax rate in IV. Quarter increased compare to previous quarter to 32.96 %, a new company high.

Looking into IV. Quarter results within Major Pharmaceutical Preparations industry 17 other companies have achieved lower Effective Tax Rate. While Effective Tax Rate total ranking has impoved so far to 1249, from total ranking in previous quarter at 1506.

HRMY's Effective Tax Rate fourth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 18
Healthcare Sector # 90
Overall # 1248

HRMY's Effective Tax Rate Statistics
High Average Low
32.96 % 18.75 % 7.2 %
(Dec 31 2023)   (Dec 31 2021)




Other Effective Tax Rate Profitability Ratios
HRMY's Cumulative Effective Tax Rate
Major Pharmaceutical Preparations Industry Effective Tax Rate Trends and Statistics
Healthcare Sector Effective Tax Rate Statistics
Effective Tax Rate Profitability Trends for overall market
HRMY's Effective Tax Rate Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Effective Tax Rate
Lowest Ranking Effective Tax Rate
Effective Tax Rate Profit Margin for HRMY's Competitors
Effective Tax Rate Profit Margin for Harmony Biosciences Holdings Inc 's Suppliers
Effective Tax Rate Profit Margin for HRMY's Customers

You may also want to know
HRMY's Annual Growth Rates HRMY's Profitability Ratios HRMY's Asset Turnover Ratio HRMY's Dividend Growth
HRMY's Roe HRMY's Valuation Ratios HRMY's Financial Strength Ratios HRMY's Income taxes expenses / -benefit Growth
HRMY's Roa HRMY's Inventory Turnover Ratio HRMY's Growth Rates HRMY's Dividend Comparisons


Companies with similar Effective Tax Rate in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Effective Tax RateDec 31 2023 MRQ Income taxes expenses / -benefitDec 31 2023 MRQ Pre-Tax Income
Phibro Animal Health Corporation  64.26 %$ 2.291 $ 3.565 
Ionis Pharmaceuticals Inc  53.30 %$ 12.079 $ 22.661 
Harmony Biosciences Holdings inc   32.96 %$ 13.082 $ 39.689 
Abbvie inc   32.01 %$ 388.000 $ 1,212.000 
Collegium Pharmaceutical Inc   31.62 %$ 14.770 $ 46.710 
United Therapeutics Corporation  26.51 %$ 78.300 $ 295.400 
Catalyst Pharmaceuticals Inc   25.40 %$ 11.863 $ 46.707 
Siga Technologies Inc  22.20 %$ 20.612 $ 92.868 
Zoetis Inc   19.54 %$ 127.000 $ 650.000 
Vertex Pharmaceuticals Inc  15.58 %$ 178.800 $ 1,147.600 
Corcept Therapeutics Inc  14.81 %$ 5.453 $ 36.808 
Astrazeneca Plc  13.60 %$ 938.000 $ 6,899.000 
Eli Lilly And Company  12.72 %$ 319.100 $ 2,508.800 
Prestige Consumer Healthcare Inc   11.88 %$ 16.529 $ 139.150 
Abbott Laboratories  11.20 %$ 201.000 $ 1,795.000 
Teva Pharmaceutical Industries Limited  8.46 %$ 40.000 $ 473.000 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com